The Flexagon system. [Image from the GI Windows Surgical website]GI Windows Surgical announced today that it secured $37 million in additional funding to support its Flexagon self-forming magnet.

Flexagon系统。[图片来自GI Windows Surgical网站]GI Windows Surgical今天宣布，它获得了3700万美元的额外资金，以支持其Flexagon自成型磁铁。

Westwood, Massachusetts-based GI Windows plans to use the funds to support the continued clinical development and planned commercialization of Flexagon and delivery systems. It designed its technology to employ magnetic anastomosis to enable less invasive surgery.

总部位于马萨诸塞州韦斯特伍德的GI Windows计划使用这些资金支持Flexagon和输送系统的持续临床开发和计划商业化。它设计的技术采用磁性吻合，以实现微创手术。

GI Windows aims to develop the first fundamental breakthrough in anastomoses technology in both delivery and tissue fusion.

GI Windows旨在开发吻合技术在输送和组织融合方面的第一个根本突破。

Orlando Health Ventures led the most recent financing round. Rex Health Ventures also joined in, while participating investors took part as well. Those include Johnson & Johnson Innovation-JJDC, JCInvestco and Dr. Fred Moll, a pioneer in surgical robotics. GI Windows reports an additional strategic investor participating, too..

奥兰多健康风险投资公司领导了最近一轮融资。Rex Health Ventures也加入了进来，参与的投资者也参加了。其中包括强生创新JJDC、JCInvestco和外科机器人先驱弗雷德·摩尔博士。GI Windows也报告了另外一家战略投资者的参与。

Yuriy Onyskiv of Orlando Health Ventures said in a news release that the venture firm “saw this as a great opportunity to partner with a strong leadership team and an exciting technology to reshape the future of surgical procedures and bring tangible benefits to the healthcare system.”

奥兰多健康风险投资公司（Orlando Health Ventures）的尤里·奥尼斯基（YuriyOnyskiv）在新闻稿中表示，该风险投资公司“认为这是一个很好的机会，可以与强大的领导团队和令人兴奋的技术合作，重塑外科手术的未来，并为医疗保健系统带来切实的好处。”

“I am pleased to see providers joining leading medtech companies to invest in the future of healthcare” said Brian Tinkham, CEO of GI Windows Surgical. “We believe our team will revolutionize the surgical landscape, with the proceeds of this financing targeting enrollment of an FDA IDE clinical trial and commercial launch in the U.S.

“我很高兴看到供应商加入领先的医疗技术公司，投资于医疗保健的未来”，GI Windows Surgical首席执行官布赖恩·廷克姆（BrianTinkham）表示。“我们相信，我们的团队将彻底改变外科领域，这笔资金的收益将针对FDA IDE临床试验的注册和在美国的商业启动。

in 2025”..

2025年”